A Trial of the Beta-Blocker Bucindolol in Patients with Advanced Chronic Heart Failure
Top Cited Papers
Open Access
- 31 May 2001
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 344 (22), 1659-1667
- https://doi.org/10.1056/nejm200105313442202
Abstract
Although beta-adrenergic–receptor antagonists reduce morbidity and mortality in patients with mild-to-moderate chronic heart failure, their effect on survival in patients with more advanced heart failure is unknown.Keywords
This publication has 34 references indexed in Scilit:
- Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)The Lancet, 1999
- Racial Differences in the Outcome of Left Ventricular DysfunctionNew England Journal of Medicine, 1999
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- EditorialThe American Journal of Cardiology, 1997
- The Effect of Digoxin on Mortality and Morbidity in Patients with Heart FailureNew England Journal of Medicine, 1997
- Adverse consequences of high sympathetic nervous activity in the failing human heartJournal of the American College of Cardiology, 1995
- Comparison of sestamibi single-photon emission computed tomography with positron emission tomography for estimating left ventricular myocarclial viabilityThe American Journal of Cardiology, 1995
- Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockadeJournal of the American College of Cardiology, 1995
- Epidemiology of heart failure in the United StatesAmerican Heart Journal, 1993
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984